You are viewing the site in preview mode

Skip to main content

Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study

The Original Article was published on 18 December 2024

Correction: BMC Medicine 22, 585 (2024)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-024-03801-5


The authors wish to revise the Data Availability statement with the following:

The transcriptome sequencing and DNA panel sequencing data from the current study are available in the OMIX repository [https://ngdc.cncb.ac.cn/omix/release/OMIX008800, https://ngdc.cncb.ac.cn/omix/release/OMIX008802] [1, 2].

References

  1. Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics Proteomics Bioinformatics. 2021;19(4):578–83.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Members C-N, Partners. Partners. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2024. Nucleic Acids Res. 2024;52(D1):D18–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Song Li or Lian Liu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Dai, X., Liu, A. et al. Correction: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study. BMC Med 23, 83 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-025-03938-x

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-025-03938-x